|Bid||110.02 x 100|
|Ask||110.10 x 1200|
|Day's Range||99.39 - 111.69|
|52 Week Range||20.10 - 300.00|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||140.00|
Last week, Aurora Cannabis (ACB)(ACBFF) reported year-over-year revenue growth of 260% in its first quarter, which ended on September 2018. The overall revenue partially included sales from recreational cannabis. Consequently, the gross margin expanded year-over-year from 58% to 70% in the first quarter. Let’s look at how analysts’ price target and recommendations for the company have changed after the earnings.
CORAL GABLES, FL / ACCESSWIRE / November 20,2018 / Marijuana stocks have seen investors flooding the market. Cannabis industry reports continue to support the idea that the marijuana industry could be set to see strong growth within the next decade. Grand View Research reports that the global legal marijuana market size was valued at USD 9.3 billion in 2016 and is expected to exhibit a CAGR of 34.6% during the forecast period.
HENDERSON, NV / ACCESSWIRE / November 20, 2018 / Despite strong sales numbers across the cannabis industry, stocks in the sector have had rough go of it recently. This is most likely due to the overall ...
The company reported revenues of $28.3 million during the third quarter of 2018 as compared to Wall Street analyst estimates of $26.6 million (or 35.1 million Canadian dollars) during the quarter. The below chart compares revenues for Trulieve since the third quarter of 2017. The Horizons Marijuana Life Sciences Index ETF (HMMJ) holds 11.8% of its total investments in Tilray (TLRY), 0.5% in WeedMD (WMD) (WDDMF), and 1.0% in Vivo Cannabis (VVCIF).
MedMen Enterprises (MMNFF) holds 19 licensed cannabis facilities for cultivation, manufacturing, and marketing cannabis as a consumer product. This article compares MedMen’s (MMNFF) valuation with its peers’, including Tilray (TLRY), CannaRoyalty (OH), and Maricann (MRRCF).
The cannabis sector ended in negative territory last week. The Horizons Marijuana Life Sciences ETF (HMMJ) fell ~6.2%, and the ETFMG Alternative Harvest ETF (MJ) fell 5.8% during the period. Most cannabis stocks also ended in the negative territory.
MedMen (MMNFF) has entered into agreements with different companies to expand its footprint. We outline a few of the recent agreements below.
/ This month marijuana stocks have been very active. As of November 7, US Attorney General Jeff Sessions is out and an interim AG is in. This all occurred following Canada’s full legalization of recreational and medicinal cannabis.
The good news is — if you’re an investor that desires price volatility working for you rather than against you — Under Armour (NYSE:UAA), Chipotle (NYSE:CMG) and Tilray (NASDAQ:TLRY) are bear-busting stocks to buy today. Toss in decent, but not over-the-top short interest to help fuel the upside and the peace of mind that comes with owning brand recognition and a large-cap company—and the case for UAA, CMG and TLRY only grows stronger. Click to Enlarge The first of our large-cap stocks to buy is Under Armour.
Trulieve Cannabis Corp (TCNNF) is a licensed medical cannabis company set to release its Q3 2018 earnings on November 19 at 10:00 AM ET. Analysts expect Trulieve to report revenues of 35.1 million Canadian dollars for the third quarter of 2018. Trulieve is a vertically integrated cannabis company involved in the cultivation, production, and commercialization of cannabis products in the State of Florida.
Cannabis stocks have made several investors wary because of their high level of volatility. Earlier this week, some of the companies that reported earnings such as Canopy Growth (WEED), Tilray (TLRY), and Aurora Cannabis (ACB) (ACBFF) missed analysts’ estimates by a large margin, and the stocks got hammered. In an interview with CNBC, Andrew Left of Citron Research was largely pessimistic on the Canadian cannabis industry and expects that cannabis stocks will fall in the near term.
On November 15, the widely followed host of Mad Money on CNBC, Jim Cramer, gave his opinions on the cannabis industry. Cramer pointed investors to Canopy Growth (WEED) (CGC), the Canadian cannabis (HMMJ) giant, because of its backing from Constellation Brands as a result of the latter’s $4 billion investment.
There was a flurry of earnings releases this week from leaders of the Canadian cannabis industry. Here are the winners and losers.
The big financial institutions are negative right now and that means any positive light is going to be bent into negative light, Jim Cramer told his Mad Money viewers on Thursday evening. Right now, all the talk is about "late cycle," as in, we're in the late stage of the economic cycle. The economy can handle the initial rate hikes from the Federal Reserve, because rates were so low to begin with, Cramer reasoned.
is still a buy, according to analysts at Cowen, who lowered the company's price target to $150 a share from $172, while maintaining their "outperform" rating. Shares of Tilray were rising about 6% on Thursday. Tilray was part of a spate of cannabis company earnings releases this week, reporting revenue of $10 million that was slightly below estimates, which sent the stock tumbling following the release.